Skip to main content
Top
Published in: Journal of Clinical Immunology 7/2016

01-10-2016 | Letter to Editor

Brain Abscess in a Child with Leukocyte Adhesion Defect: An Unusual Association

Authors: Ankur Kumar, Aman Gupta, Amit Rawat, Chirag Ahuja, Deepti Suri, Surjit Singh

Published in: Journal of Clinical Immunology | Issue 7/2016

Login to get access

Excerpt

Leukocyte adhesion deficiency (LAD) is a primary immunodeficiency caused by a defect in the adherence of neutrophils to the wall of blood vessels. This failure in adherence results in an inability of transmigration of neutrophils through the endothelium to the site of inflammation [1]. Patients with LAD are predisposed to severe and life-threatening bacterial infections from birth. Three types of LAD have been identified thus far [2], namely (i) LAD type I with defect in the ITGB2 gene encoding for CD18, (ii) LAD type II with defect in the SLC35C1 gene encoding for CD15, and (iii) LAD Type III with defect in the FERMT3 gene encoding the Kindlin 3 protein. Patients with LAD fail to develop pus at the site of infection because of an inability of neutrophils and monocytes to egress the circulation and reach the site of inflammation. The most common clinical manifestations include recurrent infections, poor wound healing, ulcers in the oral cavity, and skin abscesses [3]. Delayed separation of the umbilical cord (usually 3 weeks after birth) and omphalitis is a hallmark clinical manifestation of this immunodeficiency albeit not always present. Marked neutrophilic leukocytosis in the peripheral blood is the hallmark laboratory abnormality. Besides, patients with LAD III also have defective platelet aggregation leading to bleeding manifestations and an osteopetrosis phenotype because of a defect in osteoclasts [2]. We report brain abscess in a child with LAD type I, a hitherto unreported clinical presentation in LAD. …
Literature
1.
go back to reference Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol. 2009;38(1):54–60.CrossRef Etzioni A. Defects in the leukocyte adhesion cascade. Clin Rev Allergy Immunol. 2009;38(1):54–60.CrossRef
2.
go back to reference van de Vijver E, van den Berg TK, Kuijpers TW. Leukocyte adhesion deficiencies. Hematol Clin. 2013;27(1):101–16.CrossRef van de Vijver E, van den Berg TK, Kuijpers TW. Leukocyte adhesion deficiencies. Hematol Clin. 2013;27(1):101–16.CrossRef
3.
go back to reference Movahedi M, Entezari N, Pourpak Z, Mamishi S, Chavoshzadeh Z, Gharagozlou M, et al. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J Clin Immunol. 2007;27(3):302–7.CrossRefPubMed Movahedi M, Entezari N, Pourpak Z, Mamishi S, Chavoshzadeh Z, Gharagozlou M, et al. Clinical and laboratory findings in Iranian patients with leukocyte adhesion deficiency (study of 15 cases). J Clin Immunol. 2007;27(3):302–7.CrossRefPubMed
4.
go back to reference Madkaikar M, Currimbhoy Z, Gupta M, Desai M, Rao M. Clinical profile of leukocyte adhesion deficiency type I. Indian Pediatr. 2012;49(1):43–5.CrossRefPubMed Madkaikar M, Currimbhoy Z, Gupta M, Desai M, Rao M. Clinical profile of leukocyte adhesion deficiency type I. Indian Pediatr. 2012;49(1):43–5.CrossRefPubMed
5.
go back to reference Madkaikar M, Italia K, Gupta M, Chavan S, Mishra A, Rao M, et al. Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: identification of 9 novel mutations. Blood Cells Mol Dis. 2015;54(3):217–23.CrossRefPubMed Madkaikar M, Italia K, Gupta M, Chavan S, Mishra A, Rao M, et al. Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: identification of 9 novel mutations. Blood Cells Mol Dis. 2015;54(3):217–23.CrossRefPubMed
6.
go back to reference Stepensky PY, Wolach B, Gavrieli R, Rousso S, Ben Ami T, Goldman V, et al. Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation. J Pediatr Hematol Oncol. 2015;37(4):264–8.CrossRefPubMed Stepensky PY, Wolach B, Gavrieli R, Rousso S, Ben Ami T, Goldman V, et al. Leukocyte adhesion deficiency type III: clinical features and treatment with stem cell transplantation. J Pediatr Hematol Oncol. 2015;37(4):264–8.CrossRefPubMed
7.
go back to reference Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, et al. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol. 2010;30(5):756–60.CrossRefPubMed Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, et al. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol. 2010;30(5):756–60.CrossRefPubMed
8.
go back to reference Yamazaki-Nakashimada M, Maravillas-Montero JL, Berrón-Ruiz L, López-Ortega O, Ramírez-Alejo N, Acevedo-Ochoa E, et al. Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1). Immunol Res. 2015;61(3):260–8.CrossRefPubMed Yamazaki-Nakashimada M, Maravillas-Montero JL, Berrón-Ruiz L, López-Ortega O, Ramírez-Alejo N, Acevedo-Ochoa E, et al. Successful adjunctive immunoglobulin treatment in patients affected by leukocyte adhesion deficiency type 1 (LAD-1). Immunol Res. 2015;61(3):260–8.CrossRefPubMed
Metadata
Title
Brain Abscess in a Child with Leukocyte Adhesion Defect: An Unusual Association
Authors
Ankur Kumar
Aman Gupta
Amit Rawat
Chirag Ahuja
Deepti Suri
Surjit Singh
Publication date
01-10-2016
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 7/2016
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-016-0315-0

Other articles of this Issue 7/2016

Journal of Clinical Immunology 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.